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Abstract  
In addition to study the genetic information of capsular polysaccharide gene by PCR assay .This 
study is also, aimed to determine the molecular serotyping among different environmental resources 
samples of Cryptococcus neoformans, by using phenotypic and molecular techniques. 
So, this study is designed to investigate the molecular serotyping of C. neoformans at a genetic 
level in order to identify the serotypes belong to this yeast and to differentiate them from each other. 
To achieve these goals, environmental resources samples were collected from different area of 
Najaf province during (2015). Culture tests are done for samples in The same aspect includes  
identification by molecular methods. The polymerase chain reaction method (PCR) is used to identify 
the Cryptococcus serotype genetically. Depending on amplification of genomic DNA, the entire 
isolates are diagnosed as Cryptococcus yeasts. However, the most recurring species are the C. 
neoformans that rated 80%, while the C. gattii that rated 20% is the less recurring one. The results of 
amplifing the genomic DNA, using specific primer, show bands with molecular weight that is (387 bp) 
approximately for 12 isolates. However, the other species showed band with molecular weight that was 
(359 bp).  
The  isolates are diagnosed genetically using the RFLP – PCR method as restriction enzyme with 
(Bsm F1, Hpa II) through which systematic important information appears for the genetic relations in 
the studied isolates that are related for two types. 
PCR assay revealed that five different serotypic patterns are detected as: serotype A ,serotype B , 
serotype C , serotype D and serotype AD .It can be concluded that the PCR targeting the genomic DNA 
and the REFP – PCR are rapid and simple techniques for serotyping C. neoformans and are useful not 
only for discrimination of C. neoformans from its related species, but also for epidemiological study at 
the molecular level. This study provides the detection genetically serotyping of C. neoformans which is 
isolated from different environmental resources in Najaf province 
Key words: Cryptococcus neoformans, Cryptococcus gattii, environmental sorces, Molecular 
serotyping, PCR, REA-PCR.     
 
 ةصلاخلا 
 ةفاضلإاب  ةلوسبكلا( ثرومل ةفرعم ىلا59 نم ةذوخأملا تلازعلا جذامن يف ةرملبلا ميزنا ةلسلس لعافت ةينقت لامعتساب )م ةيئيب رداص
 زجلا طيمنتلا ىلا ةيلاحلا ةساردلا تفده كلذكو ةفلتخميةئيبخلا تاروكملا ةريمخل ةفلتخم ةيئيب رداصم نم تلازع نمض يئ ،  مادختساب
 ةيرهظملا تاينقتلا ضعبةيئيزجلاو. 
حص لكاشم ببست دق يتلاو ةفلتخم ةيئيب رداصم نم ةلوزعملا ةيديزابلا تايرطفلا نم ةئيبخلا تاروكملا ةريمخ ربتعت ريطخ ةي ة
ئيبخلا تاروكملا رئامخل يئيزجلا طيمنتلا نع يرحتلل ةساردلا هذه تممص دقو ،ًايعانم نيطبثملا ىضرملا صخلاابو ناسنلال ىلع ة
 يثارولا ىوتسملا.اهنيب زييمتلاو ةريمخلا هذهل ةدئاعلا ةيلصملا طامنلاا ديدحتل 
 وةرملبلا ميزنا ةلسلس لعافت صحف مادختساب تايركسلا ةددعتملا )ةظفحملا( ةلوسباكلا نيجل ةيئيزجلا ةساردلل نمضت أ ًاضي 
ثارو ةروصب ةريمخلل يلصملا طمنلا صيخشتل ةرملبلا ميزنا ةلسلس لعافت ةقيرط مادختسا مت دقف ،ةيئيزجلا قرطلاب صيخشتلالااب ةي دامتع
 ـلا ميخضت ىلعDNA وه ًاددرت رثكلاا عونلا ناك كلذ نع ًلاضف ،ةئيبخلا تاروكملا ةريمخك تلازعلا صيخشت مت .neoformans  
نيب يلكلا ددعلا غلب عونلا امgattii  ـلا ميخضت جئاتن ترهظا .ًاددرت لقلاا ناكوDNA مزح ،صصختملا ئدابلا مادختساب ،ب ةيئيزج نازوأ
(387 ( ـل )ةدعاق جوز12ةلزع ), ( يئيزج نزوب مزح رهظا يناثلا عونلا لاح ةيا ىلع359  زعلا صيخشت متو امك .)ةدعاق جوز تلا
ةيثارو ةروصب  طمن ىوتسم ىلعيلصم ختساب ةقيرط مادRFLP ( ةعطاقلا تاميزنلاا عمBsm F1( و )Hpa II اهللاخ نم يتلاو )
 ةقلعتم يه يتلا ةسوردملا تلازعلل ةمهم تامولعم ترهظاب.ةسوردملا ةريمخلا نم نيعونل 
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ةرملبلا ميزنا ةلسلس لعافت رابتخا رهظا  يلصملا طمنلا ،ةددحم تناك ةفلتخم ةيلصم طامنا ةسمخA , يلصملا طمنلاB ا طمنل
 يلصملاC  يلصملا طمنلاD  يلصملا طمنلاوAD اذه نمو .ةفلتخملا ةيلصملا طامنلاا نيب ترهظ دق ةيونعم تافلاتخلاا تناكو 
 ـلا ًافدهم ناك ةرملبلا ميزنا ةلسلس لعافت رابتخا ناب جتنتسنDNA  رابتخا ناكو يوونلاRFLP ل ًاينقت ًاطيسبو ًاعيرس ةريمخلا طيمنت
  ايئيزج  ًاديقمو وتسملا ىلع ةيئابولا تاساردلل ًاضيا ديفم نكلو اهب ةقلاعلا تاذ عاونلاا نع ةريمخلا قيرفتل طقف سيل  زجلا ى هذه .يئي
 ةروصب يلصملا طيمنتلا ترفو ةساردلاةيئيزج  يف ةفلتخم ةيئيب رداصم نم ةلوزعملا ةئيبخلا تاروكملا ةريمخلفجنلا ةظفاحم. 
ا يف يساسا رود اهلو ،صرفلل ةزهتنملا ةيضرملا تايرطفلا نم ةئيبخلا تاروكملا ةريمخ نأب ةساردلا هذه نم جتنتسن ثادح
 ًايعانم ةلتعملا )فئاضملا( تانئاكلا يف ضرملا–  ًايعانم ةطبثملا وا– معتساب ةساردلا هذه يف هصيخشت ديكأت مت يذلاو تائداب لا
.ةريمخلا هذهب ةصاخ 
 تاملكلالامفتاحية: ( ةيئيب رداصم ,ةئيبخلا تاروكملا(PCR,PCR,REA- .يئيزجو يلصم طيمنت , 
 
Introduction 
Cryotococcosis is potentially life-threatening invasive fungal infection and is 
often associated with disseminated disease. It mainly occurs in immunocompromised 
hosts such as acquired immunodeficiency syndrome patients and less frequently in 
immunocompetent patients. The most commonly affected sites in immunocompetent 
host are the lungs and central nervous system, while the lymph nodes usually remain 
unaffected.  
The infection process begins with inhalation of infectious agents (spores of 
dessicated yeasts) resulting in a primary pulmonary infection, which can further 
disseminate to the central nervous system causing meningitis. Cryptococci are 
particularly difficult to treat with antifungal agents due to their ability to manipulate 
and exist within the host’s immune response. 
Species in the genus Cryptococcus, C.neoformans and C.gattii. C.neoformens 
(serotypes A, D, and AD) is found worldwide and causes cryptococcosis most 
frequently in AIDS patients C. gattii (serotypes B and C) is geographically restricted 
and is infrequently diagnosed in AIDS patients (Jianghan chen, et al; 2008). 
Cryoptococcus neoformans and Cryptococcus gattii are the two etiologic agents 
of cryptococcosis. They belong to the phylum basidiomycota and can be readily 
distinguished from other pathogenic yeasts such as Candida by the presence of a 
polysaccharide capsule, formation of melanin, and urease activity, which all function 
as virulence determinants. infection proceeds via inhalation and subsequent 
dissemination to the central nervous system to cause meningoencephalitis. The most 
common risk for cryptococcosis caused by C. neoformans is AIDS, whereas 
infections caused by C. gattii are more often reported in immunocompetent patients 
with undefined risk than in the immunocompromised (Kyung  et al., 2014) 
A variety of characteristics have been implicated in C. neoformans success as a 
pathogen. The primary virulence factor of this pathogen, however, is the display of an 
elaborate polysaccharide capsule, which is required for virulence and is unique among 
the pathogenic fungi (Deepa et al., 2014). Polysaccharides impede the host immune 
response, and the size of the capsule affects phagocytosis of C. neofarmans; these in 
turn alter the balance of free and host cell-engulfed fungi, influencing key events, 
such as clearance, latency, and dissemination. Notably, capsule thickness changes 
dramatically in response to environmental conditions, mediated by signaling pathways 
that sense the host environment and detect nutrient limitation, increased temperature, 
and Co2 levels to investigate etiological agent the fungal infections cryptococcosis 
and to identify Cryptocossus by isolating from environmental sources and determine 
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the serotypes and genotypes of these environmental isolates need using rapid methods 
which are sensitive and specific for diagnosis. (Anna Vecchiarelli, et al, 2013) 
Conventional laboratory-based methods for diagnosis of fungal infection remain 
useful but are often slow and lack sensitivity. The newer rapid, sensitive and specific 
culture-independent methods for the diagnosis of Cryptococcal meningitis  offer great 
promise for improved diagnosis and management of these serious infections (Michael 
A. p faller, 2015).  
Molecular diagnosis techniques represent an important breakthrough in the 
diagnostic practice. In the present study used conventional PCR and restriction 
fragment length polymorphism analysis; two molecular methods, based on the 
sequence characteristics of a fragment of the CAP59 gone required for capsule 
biosynthesis both methods allow for the rapid and reliable identification of all C. 
neoformans serotypes. 
The aims of the present study are:  
o To assess the serotype for Cryptococcus neoformans isolates, to molecular 
techniqal uses, To determine the fungal isolate associated with the environmental 
sources in Najaf provence. 
o To determine the molecular serotype in the fungal isolate. 
 
Objective of the Study 
   and molecular technique 
o Confirmed identification of the strains and serotypes by the use of PCR technique 
by using of the Cryptococcal polysaccharide gene. 
o Molecular characterization for serotype by using the specific sequences for these 
serotypes by PCR technique, or restriction fragment length polymorphic DNA 
technique. 
The Isolation and identification of the yeast: 
The isolation was submitted to the PCR technique. 
Fermentation test: 
         This test had been used to determine the ability of the isolates to ferment 
(glucose, maltose, lactose, inositol, raffinose and sucrose) by using the carbohydrate 
broth, this test had been done by putting a colony from the growing yeast in a 
stabbing method in the test tube of the carbohydrate broth, then incubated in 30 ̊c for 
24 – 48 hrs. the changing in the color media from pink to yellow would give an 
indication of the positive results of the test. 
Identification by PCR: 
For Molecular Identification to the Cryptococcus PCR technique was used by 
utilizing primer pairs for fifteen samples. CAP59 gene amplification, two primers 
(CH-CAP 59 Forward (5ˊ- CCTTGCCGAAGTTCGAAACG -3ˊ), and CH-CAP59 
Revers (5ˊ-AATCGGTGGTTGGATTCAGTGT- 3ˊ) were designed from the 
conserved regions of the CAP59 gene. DNA was extracted using a method below.  
Preparing the primers: 
       The primers were prepared depending on manufacturer’s instructions by 
dissolving the lyophilized primers with TE buffer to form stock solution with 
concentration of 100pmol/µl, after spinning down and stay overnight at 4Co, primers 
working solution were prepared by diluted the stock solution with TE buffer, using 
the equation C1V1=C2V2 to get final working solution (20pmol/µl) for both primers. 
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Culture and Harvest the isolates: 
         Cyrptococcus isolation were growth in 3 ml Sabouraud Dextrose broth to the 
early stationary phase for 24hr at 37oC with agitation in shaking incubator. The 
cultures were harvested and concentrated by centrifugation for 5minutes at 6000rpm, 
and discarded the supernatant . Yeast cells washed 3 times with normal saline, and 
repelleted in 1.5ml eppendorf tube at 12000 rpm for 5 minutes. 
 
DNA Template Extraction and purification:  
        The Cryptococcus DNA extraction was performed according to [Promega 
technical manual] for Isolating Genomic DNA from Yeast, as follows: 
o One ml of a Cryptococcus species [culture grown for 20 hours in Sabouraud 
Dextrose broth] was added to a 1,5ml micro centrifuge tube.  
o The tubes were centrifuged at 14,000 r.p.m for 2 minutes to pellet the cells. 
The supernatant was removed.  
o The cells were resuspended thoroughly in 293µl of [50 mM EDTA]. 
o Seven and a half µl of [20mg/ml lyticase] were added and gently mixed 4 
times by pipette. 
o The samples were incubated at 37°C for 60 minutes [to digest the cell wall]. 
Then cooled to room temperature. 
o The samples were centrifuged at 14,000 r.p.m for 2 minutes and then the 
super natant was removed. 
o Three hundred µl of [Nuclei Lysis solution] were added to the cell pellet and 
gently mixed by pipette. 
o One hundred µl of [protein Precipitation solution] were added with vortex 
vigorously at high speed for 20 seconds. 
o The samples were left [on ice] for 5 minutes. 
o Centrifugation was done at 14,000 r.p.m for 3 minutes. 
o The supernatant containing [the DNA] was transferred to a clean 1.5 ml 
microcentrifuge tube containing [300 µl of room temperature isopropanol]. 
o The tubes contents were gently mixed by [inversion] until the thread – like 
[strands of DNA] form a visible mass.  
o Centrifugation was done at 14,000 r.p.m for 2 minutes. 
o The supernatant was carefully decanted and the tubes were [drained on 
clean] absorbent paper. 300 µl of room temperature 70% ethanol were added 
and the tubes were gently inverted several times to wash [the DNA pellet]. 
o Centrifugation was done at 14,000 r.p.m for 25 minutes. All of the ethanol 
was carefully aspirated. 
o The tubes were drained on [clean absorbent paper] and the pellet was 
allowed to [air dry] for 15 minutes. 
o Fifty µl of [DNA Rehydration solution] were added. 
o One point five µl of [RNase solution] were added to each purified DNA 
sample with vortex for 1 second. The tubes were centrifuged briefly for 5 
seconds to collect the liquid and incubated at 37°C for 15 minutes. 
o The DNA was [rehydrated] by incubating overnight at 4°C. 
o The DNA stored at 2°-8°C. 
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PCR of DNA samples:  
         PCR of DNA samples was carried out in a final reaction volume of 25µl in 
thermal cycler, quantity and concentration of various components used for PCR of 
DNA samples are shown in Table (1). 
 
Table (1): Quantity and concentration of various components used in PCR 
No. Various components used in PCR Concentration 
1 Robust hot start ready mix contains 2mµ MgCl2, at 1X 12.5µl 
2 Forward primer (10µm) 10 pmole/µl 2µl 
3 Reverse primer (10µm) 10 pmole/µl 2µl 
4 Template DNA (62,5 ng) 3µl 
5 Distilled water 5.5µl 
6 Final reaction volume 25µl 
 
Gene amplification: (Thermocycling conditions): 
         According to the Experimental Protocol of AccuPower® TLAPCR pre Mix 
tube, the PCR reaction mixture was prepared as follows: 
o Three µl template DNA (62.5ng) and 4µl of each primer (10 pmole/µl, 
2µl forward and 2µl reverse), were added to each [AccuPower® 
TLAPCR Pre Mix tube]. 
o Distilled water was added to [AccuPower® TLAPCR Pre Mix tubes] to 
the final volume of 25 µl. 
o The tubes were mixed with vortex to dissolve the lyophilized blue pellet, 
and briefly spined down. 
o Preforming PCR of samples (The PCR reaction conditions was listed in 
table7). 
         All sequences were amplified individually ,using [oligonucleotide primers], 
their sequence and size of the primers were listed in (table 8). As descripe by [Lee, et 
al., (2004)] 
Steps and conditions of thermal cycling in PCR were shown in table (2)  
 
Table (2): PCR cycling conditions: 
Step Temperature Time No. of cycles 
Initial denaturation 95°c 10 min. 1 cycle 
Denaturation 95°c 30 s 35 cycles 
Annealing 60°c 30 s 35 cycles 
Elongation 72°c 45 s 35 cycles 
Final elongation 72°c 7 min. 1 cycle 
Specific sense primers for Cryptococcus neoformans designed to amplify DNA 
fragment by PCR shown in table (3) 
 
 
 
 
 
 
 
 
 
Journal of Babylon University/Pure and Applied Sciences/ No.(2)/ Vol.(26): 2018 
 
320 
 
Table (3): Primers used in this study 
Organism Primer  Sequence (5-3) Length 
C. neoformans 
Cap 59 forward  CCTTGCCGAAGTTCGAAACG 
42bp 
Cap 59 reverse AATCGGTGGTTGGATTCAGTGT 
    
 
Electrophoresis and Visualization: 
         The gel electrophoresis method was done according to as follows: 
1. Preparing the Gel: 
o A 1% agarose gel or the running buffer was made by mixing 1g agarose with 
90ml distilled water and 10ml (10 X TBE buffer). 
o The mixture was heated in a microwave oven until all the agarose powder was 
melted and the solution started to boil in 250ml flask. 
o The gel solution was then left to cool (to approximately 65°c). 
o Five µl of ethidium bromide solution (10mg/ml) were added after the mixture 
was cooled, and gently mixed. 
o The gel was poured slowly into a gel rack, the comb was set at one side of the 
gel, and any bubbles in the solution removed. The gel was allowed to del (20 
to 30 minutes). 
o After 20 minutes, when the gel had solidified, the comb was removed, [the 
gel, together with the rack], was soaked into a chamber with 1 X TBE gel 
running buffer. The gel was placed with the wells facing the electrode that 
provide the negative current (Cathode). 
2. Loading and Running the Gel: 
o A DNA ladder was loaded into the first well. This was used to determine the 
absolute size of the separated DNA strand by comparing their migration with 
that of the ladder. 
o The samples were loaded into the wells (5 µl for each) without adding loading 
dye). 
o The lid of the electrophoresis champer was closed and the current was applied. 
The gel was ran at 70 volts for 1 hour. 
o The ethidium bromide stained gel was visualized under UV light and 
photographed.    
  Identification of Cryptococcus neoformans  
Finally by the polymerase chain reaction (PCR) technique using specific primers. 
Fermentation Test: 
        This test was done by using the carbohydrate broth to detect ability to ferment 
sugars, so that all the isolated of yeast do not appear any ability to ferment the sugars, 
and this appears when the color of the media do not change from the pink to the 
yellow color as Shawn in (Tab. 4). 
Assimilation Test: 
         The C. neoformans showed their ability to assimilate Glucose, sucrose, Inositol 
and in weak manner, the Raffinose all members of the genus Cryptococcus are non – 
fermentative, assimilate Inositol and produce urease,  
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Table (4): The results of sugars fermentation and assimilation 
Sugars Fermentation Assimilation 
Glucose - + 
Sucrose - + 
Lactose - - 
Maltose - - 
Inositol - + 
Raffinose - + 
           Furthermore, all the above tests were corresponding with a reference isolate of 
C. neoformans obtained from the Microbiology Department in the college of 
Veterinary Medicine in Baghdad University. 
Molecular study: 
Extraction of genomic DNA: 
         In the present study, the method used for extracting genomic DNA was 
previously described in details in chapter three. Fifteen samples of Cryptococcus spp. 
Were subjected to DNA extraction. 
           Briefly, the colonies obtained from cultures of different environmental sources 
were subject to DNA extraction utilizing (the genomic DNA mini kit/cultured).PCR 
product appeared as a single unique clear band on ethidiume bromide stain of gel 
electrophoresis. 
The confirmation by PCR: 
          The use of the PCR to identify C. neoformans at variety, serotype and even 
molecular (genotype) levels become extended to improve diagnostic tests adversity of 
methods have been developed and this were agreement with. 
Molecular diagnosis by conventional PCR methods: 
           Molecular diagnosis had been made by conventional PCR for senotype 
determine for fifteen isolates, where complete genome was used, DNA template, by 
primer pairs, for isolated samples in this study, so all isolates were diagnosed as 
Cryptococcus, C. neoformans has been the most frequently. 
            The amplification result showed bands with molecular weight ~ 387bp for 
fifteen isolates of Cryptococcus, so these results were agreed with (Enache-  
Angaulvant et al, 2007). 
 
Molecular diagnosis by PCR- RFLP methods: 
         From this method, important and clear classified information were obtained 
from the  relationship between C. neoformans spp., so in order to established clear 
molecular serotype for isolated yeast used in this study, amplification product had 
been obtained by the primer pairs specific with capsular polysaccharide gene (Cap 
59), two restriction enzymes (HpaII) (BsmF1) had been used, so that results for 
digestion product with the two restriction enzymes, had been shown that there were 
variation in the studied serotype according to the band type in agarose gel 
electrophoresis. 
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             M     1     2     3    4      5     6    7      8      9   10    11   12   13   14    15 
 
 
 
 
 
 
 
 
 
(Fig.1): Electrophoresis amplification product on agarose gel for fifteen isolates 
of C. neoformans (387bp) 
M: present the DNA marker (100bp). Lane: 1-15 indicate to fifteen isolates of C. 
neoformans (agarose gel 2%, 85 volt, 1.5hour). 
 From the resultes above that the band size was (387bp)and refers to the PCR product 
was Cryptococcus neoformans. 
(Fig.2): Electrophoresis amplification product on agarose gel for fifteen isolates 
of C. neoformans  
M: present the DNA marker (100bp). Lane:1-15 PCR product of C.neoformans/ 
C.gattii complex   
(agarose gel 2%, 85 volt, 1.5hour). 
All No.1 indicates to Amplicon(PCR product) 
All No.2 Indicates to restriction enzyme   BsmFI that was used in this study  
All No.3 indicates to restriction enzyme   HpaII that was used in this study 
          
 From the figure above the results show that the enzyme BsmFI  was used for all 
isolated, but it works on serotype A,AD and did not work on another, serotype  and 
this refers to the restriction site did not find in this fragment. 
        The definitive diagnosis of invasive fungal infections is usually based upon the 
isolation and identification of a specific etiologic agent in culture, and/or on the 
microscopic demonstration of the etiologic agent in histopathologic or other clinical 
specimens. The management of invasive fungal infections is, however, often 
hampered by difficulties in obtaining good specimens for histopathologic or 
microbiologic investigation, and by the fact that fungal cultures sometimes become 
positive only late in the infection. In this situation, other methods are essential to 
allow early diagnosis and treatment. New procedures, based on the detection of fungal 
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DNA in clinical material, are presently being developed (Chen, S.C., et al, 2002; Yeo, 
S.F., et al, 2002). These molecular tests offer great hope for the rapid detection and 
identification of difficult-to-culture organisms, and for rapid diagnosis directly from 
clinical samples. However, few DNA-based tests are currently available for routine 
clinical use.  
          The PCR assay was shown to be a valuable tool for detecting Cryptococcus 
organisms from different  samples from infected organs content and that were 
consistent with (Al-Tamemy, 2009). Several advantages were reported for the PCR 
assay over the current conventional methods used to identify Cryptococcus species, 
the major advantage being the time taken compared to conventional methods which 
require several days to isolate and identify the organism, and that were agreement 
with. Another advantage is the need for minimal sample preparation because isolation 
of living organisms is not necessary. The assay is also not affected by contamination 
with other microbes that might be present in samples for isolation ,and that were 
constant with. 
Amplification of DNA by PCR: 
           Amplification of DNA [extracted from colonies] was positive in all samples. 
According to the primer size, the amplicon runs at the level of 387bp on gel 
electrophoresis compared to a control DNA marker size. 
Amplification of DNA reviled the presence of a single amplified product at the level 
387bp in (15) samples of the environmental sources. 
 
From the results show in the figure (1) the current study have diagnosed the 
Cryptococcus as shown in table (5): 
Lane1: serotype A variety grubii 392bp 
lane2: serotype A variety grubii 392bp 
Lane3: serotype A variety grubii 392bp 
Lane4: serotype B C. gattii 387bp 
Lane5: serotype B C. gattii 387bp 
Lane6: serotype B C. gattii 387bp 
Lane7: serotype C C. gattii 359bp 
Lane8: serotype C C. gattii 359bp 
Lane9: Serotype C  C. gattii 359bp 
Lane10: Serotype D variety neoformans 375bp 
Lane11: Serotype D variety neoformans 375bp 
Lane12: Serotype D variety neoformans 375bp 
Lane13: Serotype AD C. neoformans 387bp 
Lane14: Serotype AD C. neoformans 387bp 
Lane15: Serotype AD C. neoformans 387bp 
              From the results mentioned above, the present study showed that the PCR 
products  that runs on agarose gel electrophoresis, treated with two restriction 
enzymes (BsmF1, HpaII), have different molecular weight, ranging from (359bp – 
392bp), so the DNA band from serotype A have the highest molecular weight of 
392bp, serotype B have the molecular weight of 387bp, serotype C have the lowest 
molecular weight of 359bp, serotype D have the molecular weight of 375bp, and the 
serotype AD have the molecular weight (as the serotype B) of 387bp. 
        From these results, explanation for the presence of multiple band in lines (2,6, 
9,12,14,15) is due to the action of restriction enzymes, these multiple bands belong to 
Cryptococcus neoformans serotype AD (hybrid) lane 13,14,15 multiple bands belong 
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to Cryptococcus gattii serotype B, lane 4,5,6, multiple bands belong to C. neoformans 
serotype A lone 1,2,3, multiple bands belong to C. gattii serotype C lone 7,8,9, and so 
on.   
         The results obtained by (Enache- Angoulvant A. et al., 2007) confirmed these 
data, showing that two molecular methods (PCR – restriction enzyme analysis and 
length polymorphism analysis) for C. neoforinans serotype identification. Both are 
based on the sequence characteristics of a fragment of the CAP 59 gene required for 
capsule biosynthesis. 
PCR-REA 
            Enzymatic restriction with BsmFI and HpaII gave three different patterns for 
serotypes A, D, and (B and C). Serotype AD strains exhibited a mixed A and D 
restriction profile. All strains were tested, and no profile variation among strains of a 
given serotype was observed. Serotype D and serotypes B and C, while having similar 
profiles (unique cutting site for HpaII and no cutting site for BsmFI), can be easily 
differentiated based on the size difference of the digested fragments. Serotypes B and 
C can be further differentiated by [AgeI digestion not used in this study] and gel 
electrophoresis. Two fragments corresponding to serotype B strains (one cutting site) 
were detected, while serotype C amplicons remained unchanged (no cutting site). 
            The current study based on molecular analysis of a fragment of the CAP59 
gene appeared to be sensitive and specific, providing interpretable results for all C. 
neoformans sample tested (Guilhem, j., et al, 2003). 
           PCR-REA is an easy-to-use approach and requires only common molecular 
materials. Its value for distinguishing among fungal species has already been 
emphasized that were agreement with (Guilhem, j., et al, 2003). serotype 
identification by combining separate digestions with BsmFI and HpaII, followed by 
subsequent digestion with [Agel] that was not used in this study when the pattern 
suggests a B or C serotype, can therefore be proposed (Table 6).  
 
Table (6): Expected sizes (bp) of CAP59 gene fragments from different serotypes 
before and after restriction with BsmFI, HpaII enzymes 
Assay or fragment A B C D AD 
Native amplicon 392 387 359 375 387 
REA with BsmFI 201, 191 NRS NRS NRS 210,177 
REA with HpaII NRS 270, 117 256, 103 211, 162  
NRS, no restriction site. 
 
          More recently, serotyping has played a major role in the investigation of the 
endemic infection on Vancouver Island (Kidd, S.E., et al, 2004). Serotyping has no 
diagnostic value, but different treatments and outcomes corresponding to serotypes 
have been reported  that use agrees with (Chen, Y.C., et al, 2000). Thus, considering 
that [the Crypto check kit (latron, Japan)] is no longer available, and in view of the 
relative complexity of obtaining monoclonal antibodies, new techniques need to be 
developed for the typing of C. neoformans strains. 
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